OTC Deal Musings
Executive Summary
With its management unsettled, a prescription business yet to show much success, and big exposure in the OTC cough-cold market, Procter &Gamble is stepping up to buy ex-North American OTC marketing rights to UCB's antihistamine Zyrtec.